Amid the new Omicron variant outbreak vaccine providers and their stocks find themselves in the spotlight. Take a look at how these stocks are behaving.

AEZS announced the opening of a new clinical site at the Hollings Cancer Center of the Medical University of South Carolina. MRNA announced they have amended their license agreement regarding the development and commercialization of microRNA-based therapeutics.